Neuropsychopharmacology Reports. 2019;39:306-311. wileyonlinelibrary.com/journal/nppr
| INTRODUC TI ONAlzheimer's disease (AD), which is the most common cause of dementia, is a progressive neurodegenerative disorder that significantly affects patients' cognitive function and their quality of life. In the brains of AD patients, accumulated amyloid beta (Aβ) is one of the major pathological characteristics of AD. 1 Aβ has been linked to cognitive dysfunction in AD patients 2 partly because Aβ induces abnormalities in synaptic function and structure, including the loss of synapses. 3,4 In the healthy brain, specifically during development, neuronal activity plays a key role in regulating the formation and elimination of synapses. 5 It has also been suggested that, in the AD brain, synapse density is influenced by neuronal activity. 6 However, confirmation of a direct link between neuronal activity and Aβ-induced synapse loss is lacking. Here, we directly investigated whether neuronal activity modulates Aβ-induced synapse loss using primary cultures of hippocampal neurons.
| ME THODSHippocampal neuronal cultures were prepared from postnatal day 1 B57BL6/J mice (SLC, Shizuoka, Japan) as previously described. 7 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
AbstractAim: The accumulation of amyloid beta (Aβ) is one of the characteristics of Alzheimer's disease. The excessive accumulation of Aβ has been suggested to result in a decrease in the number of synapses. Although the number of synapses is generally modulated by neuronal activity, whether neuronal activity affects Aβ-induced synapse loss remains unknown. Therefore, we addressed this question using a primary culture of hippocampal neurons.
Method:The neuronal activity of cultured hippocampal neurons from mouse pups was increased using the chemogenetic technique designer receptors exclusively activated by designer drugs (DREADD). The cultured neurons were treated with Aβ, and synapse density was assessed by immunocytochemistry.Results: Aβ decreased the synapse density probably by decreasing postsynapse. On the other hand, enhanced neuronal activity did not affect the synapse density significantly. However, there was a trend that enhanced neuronal activity increased especially presynapse density.
Conclusion:We found that enhanced neuronal activity did not affect Aβ-induced synapse loss in vitro.
K E Y W O R D SAlzheimer's disease, amyloid beta, hippocampus, neuronal activity, synapse | 307 KONO et al.